Jul 4, 2019
Many early-stage diagnostic companies fail because they have an ineffective reimbursement strategy. These companies develop a great test but are not aware of how to maximize reimbursement with private and government payors. During this podcast, you will learn from an expert in managed care industry on how to avoid making costly mistakes that could ruin your company. You will also learn high to generate additional revenue streams for oncology, infectious disease, and other high-value tests.